Fluoxetine suppresses calcium signaling in human T lymphocytes through depletion of intracellular calcium stores by Gobin, Veerle et al.
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a  b  s  t  r  a  c  t
Selective  serotonin  reuptake  inhibitors,  such  as  ﬂuoxetine,  have  recently  been  shown  to exert  anti-
inﬂammatory  and  immunosuppressive  effects.  Although  the  effects  on  cytokine  secretion,  proliferation
and  viability  of  T lymphocytes  have  been  extensively  characterized,  little  is  known  about  the  mechanism
behind  these  effects.  It  is well  known  that  Ca2+ signaling  is  an  important  step  in the  signaling  transduc-
tion  pathway  following  T cell receptor  activation.  Therefore,  we investigated  if ﬂuoxetine  interferes  with
Ca2+ signaling  in  Jurkat  T lymphocytes.  Fluoxetine  was  found  to suppress  Ca2+ signaling  in  response  to
T  cell  receptor  activation.  Moreover,  ﬂuoxetine  was found  to deplete  intracellular  Ca2+ stores,  thereby
2+ 2+
SRI
 lymphocyte
alcium signaling
nsitol 1,4,5-trisphosphate
yanodine receptor
leaving  less  Ca available  for release  upon  IP3-  and  ryanodine-receptor  activation.  The  Ca -modifying
effects  of  ﬂuoxetine  are  not  related  to its capability  to block  the  serotonin  transporter,  as  even a large
excess  of  5HT  did  not  abolish  the  effects.  In  conclusion,  these  data  show  that  ﬂuoxetine  decreases  IP3-
and  ryanodine-receptor  mediated  Ca2+ release  in Jurkat  T lymphocytes,  an  effect  likely to  be at  the  basis
of  the  observed  immunosuppression.
©  2015  The  Authors.  Published  by Elsevier  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND. Introduction
Selective serotonin reuptake inhibitors (SSRIs) have been shown
o exert anti-inﬂammatory and direct immunosuppressive effects
uch as suppression of T cell activation, cytokine secretion and
roliferation and induction of apoptosis in vitro and in vivo [1–3].
lthough it has been shown that these compounds have a high
fﬁnity for the serotonin transporter (SERT) in the central ner-
ous system, it is not clear whether the immunological effects of
SRIs are mediated by inhibition of SERT-mediated serotonin (5HT)
ptake in lymphocytes. On the contrary, several arguments oppose
o the involvement of 5HT and SERT in the immunosuppressive
ffects of SSRIs, especially the discrepancy between the concentra-
ion needed for blockage of 5HT uptake on the one hand (nM range)
nd for in vitro immunosuppression on the other hand (M range)
4,5]. The actual mechanism underlying the immunosuppressive
ffects of SSRIs has not been elucidated yet.
∗ Corresponding author. Tel.: +32 09 264 80 67; fax: +32 09 220 66 88.
E-mail address: Dieter.Deforce@Ugent.be (D. Deforce).
1 These authors contributed equally.
ttp://dx.doi.org/10.1016/j.ceca.2015.06.003
143-4160/© 2015 The Authors. Published by Elsevier Ltd. This is an open access article 
/).license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Elevation of the cytoplasmic free Ca2+ concentration ([Ca2+]i) is
one of the key triggering signals for T cell activation. The [Ca2+]i
is regulated through an intimate interplay between Ca2+ in the
extracellular space and intracellular storage sites such as the endo-
plasmic reticulum (ER). Ca2+ signaling mechanisms mostly rely
on Ca2+ release from the ER through inositol 1,4,5-trisphosphate
receptors (IP3R) and ryanodine receptors (RyR) following the acti-
vation of G-protein coupled receptors on the plasma membrane.
Subsequent depletion of the ER triggers store-operated, capacita-
tive Ca2+ entry to replenish the ER [6]. SSRIs have been shown
to affect Ca2+ signaling in several cell types. Fluoxetine inhibited
ATP-induced Ca2+ increases in PC12 cells through inhibition of
both inﬂux of extracellular Ca2+ and release of Ca2+ from intra-
cellular stores [7]. Whereas ﬂuoxetine has also been shown to
suppress Ca2+ spikes in cultured rat hippocampal neurons, two
other SSRIs, namely paroxetine and citalopram, did not [8]. Further-
more, chronic exposure of astrocytes to ﬂuoxetine diminished RyR-
and IP3R-mediated Ca2+ release as well as the subsequent capac-
itative Ca2+ entry [9]. In microglia, pretreatment with paroxetine
or sertraline reduced the amplitude of the Ca2+ increase induced
by interferon-gamma (IFN) [10]. Oppositely, sertraline induced
a Ca2+ rise in MG63 osteosarcoma cells [11]. Fluoxetine, paroxet-
ine and citalopram induced a rise in [Ca2+]i in Burkitt lymphoma
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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ells [12]. In platelets, SSRIs (sertraline, paroxetine, ﬂuoxetine)
otentiated thrombin-mediated increases in intracellular Ca2+ [13].
learly, SSRIs are capable of interfering with Ca2+ signaling in a
ide variety of cell types. Furthermore, it has been suggested that
uoxetine interferes with mitogen-induced Ca2+ inﬂux in murine
nd human T lymphocytes as ﬂuoxetine exerted similar effects as
he Ca2+ ionophore A23187 on T cell proliferation, protein kinase C
PKC) degradation and cAMP levels [14,15].
Given the importance of Ca2+ signaling in T cell activation [6], we
nvestigated whether interference with Ca2+ signaling might be at
he basis of the immunosuppressive effects of ﬂuoxetine in Jurkat
 lymphocytes. In addition, we investigated whether the observed
ffects on Ca2+ signaling are related to the inhibition of 5HT
ptake.
. Experimental procedures
.1. Cell culture
Jurkat T cells, clone E6-1, were cultured at 37 ◦C and 5% CO2 in
PMI supplemented with 10% heat-inactivated fetal bovine serum,
% glutamine and 1% penicillin/streptomycin (100 U/ml penicillin
; 100 g/ml streptomycin). All cell culture reagents were pur-
hased from Life technologies (Carlsbad, CA, USA).
.2. Buffers and chemicals
Krebs HEPES buffer contained 133.5 mM NaCl, 5.9 mM KCl,
.2 mM MgCl2, 11.6 mM HEPES, 11.5 mM glucose and 1.5 mM
aCl2, pH 7.4. In Ca2+-free Krebs buffer, CaCl2 was replaced
y 4.5 mM EGTA (pH 7.4) preserving equimolarity with the
rebs HEPES buffer. No external 5HT was added to the buffer.
,2-Bis(2-aminophenoxy) ethane-N,N,N′,N′-tetraacetic acid
etrakis-acetoxymethyl ester (BAPTA-AM), d-myo-inositol 1,4,5-
risphosphate, P4(5)-1-(2-nitrophenyl)ethyl ester (“NPE-caged
P3”), dextran Texas Red 10,000 MW (DTR), ﬂuo3-AM and thapsi-
argin were purchased from Molecular Probes, Life technologies.
affeine was from Sigma–Aldrich (St. Louis, MO,  USA), ryanodine
rom Abcam (Cambridge, UK) and ﬂuoxetine from ABC chemicals
Woutersbrakel, Belgium).
.3. Visualization of intracellular Ca2+
Dynamic changes in [Ca2+]i were monitored using ﬂuo3-AM.
ells in suspension were loaded with 5 M ﬂuo3-AM at 2 × 106/ml
n Krebs buffer for 1 h at room temperature and subsequently
ashed 3× in Krebs buffer. Thereafter, cells (0.5–1 × 106) were
llowed to adhere on poly-l-lysine (0.1%) coated 18 mm diameter
lass coverslips and left for 30 min  at room temperature for de-
steriﬁcation and settling on the dish. Cells were washed once in
rebs buffer to remove any unbound cells before imaging.
Intracellular Ca2+ imaging was performed in Krebs buffer at
oom temperature and was carried out using a Nikon Eclipse
E300 inverted epiﬂuorescence microscope (Nikon Belux, Brus-
els, Belgium), equipped with a 40× oil-immersion objective
Plan Fluor, NA 1.30; Nikon) and an EM-CCD camera (QuantEMTM
12SC CCD camera, Photometrics, Tucson, AZ). We  used a Lambda
G-4 ﬁlterswitch (Sutter Instrument Company, Novato, CA) to
eliver excitation at 482 nm and captured emitted light via a
05 nm long-pass dichroic mirror and a 535 nm bandpass ﬁlter
35 nm bandwidth). Images (1/s) were generated with custom-
enerated QuantEMframes software written in Microsoft Visual
++ 6.0. Fluo3 ﬂuorescence-intensity changes were analyzed with
ustom-developed FluoFrames software (generated by L.L., Ghent
niversity, Belgium). Background ﬂuorescence was  subtracted 58 (2015) 254–263 255
from all images. Traces of individual cells were obtained by point
analysis in FluoFrames software.
2.4. Electroporation loading with NPE-caged IP3 and
photoliberation
In order to study IP3-mediated Ca2+ release from the ER, T
cells were loaded with NPE-caged IP3 through electroporation,
as described elsewhere [16]. Brieﬂy, cells seeded on coverslips
were washed 3× with a low conductivity electroporation buffer
(4.02 mM KH2PO4, 10.8 mM K2HPO4, 1.0 mM MgCl2, 300 mM sor-
bitol, 2.0 mM HEPES, pH 7.4). The coverslips were then placed on
the microscopic stage, 400 m underneath a parallel wire Pt–Ir
electrode and electroporated in the presence of 10 l electropo-
ration buffer containing 100 M NPE-caged IP3 and 100 M DTR
to visualize the electroporation zone. Electroporation was  done
with 50 kHz bipolar pulses applied as trains of 10 pulses of 2 ms
duration each and repeated 15 times. The ﬁeld strength was 100 V
peak-to-peak applied over a 500 m electrode separation distance.
After electroporation, cells were thoroughly washed with Krebs
buffer. Electroporation was  performed after ﬂuo3 loading and did
not result in loss of ﬂuo3 from the cells [17].
After loading with NPE-caged IP3, coverslips were transferred to
the microscope stage for Ca2+ imaging. Photoliberation of IP3 was
done by spot (20 m diameter) illumination with 1-kHz pulsed UV
light (349 nm UV laser Explorer, Spectra-Physics, Newport, Utrecht,
The Netherlands) applied during 50 ms  (50 pulses of 90 J energy
measured at the entrance of the microscope epiﬂuorescence tube).
2.5. Activation with anti-CD3/CD28 beads
T cell receptor activation was achieved by adding magnetic par-
ticles coated with antibodies against CD3 and CD28 (Dynabeads®
Human T-Activator CD3/CD28, Life technologies) at a concentra-
tion of 25 l per 106 cells (1:1 bead:cell ratio). Cells were visually
inspected under the microscope at the end of each experiment
to determine which cells were making contact with at least one
magnetic bead.
2.6. Data analysis
The statistical analysis was  conducted in ‘R’ [18]. Homoscedas-
ticity and normality of residuals were visually checked using
residuals vs ﬁtted plots and QQ plots. If necessary, power trans-
formations were applied, using a Box–Cox plot for guidance [19].
The datasets in Sections 3.1, 3.4 and 3.7 were analyzed using a
one-way ANOVA or two-way ANOVA (to correct for the possible
inﬂuence of time if the experiment was conducted for >1 day). The
other datasets (Sections 3.2, 3.3, 3.5 and 3.6) were analyzed using
the non-parametric Kruskal–Wallis test. Student’s T tests (para-
metric) or Wilcoxon rank sum tests (non-parametric) were used
for post hoc testing with a Holm–Bonferroni correction for multiple
testing being applied. Data are presented as mean ± SD or median
and range, for parametric and non-parametric data, respectively.
Signiﬁcance was  set at p < 0.05, all tests were two-tailed.
Data are visually presented as boxplots showing median, ﬁrst
and third quartile. Whiskers represent lowest and highest data
within 1.5 interquartile range (IQR). Data exceeding the 1.5 IQR
were omitted from the graphs for clarity.
2.7. Digital droplet (dd)PCRmRNA was isolated using the RNeasy® mini kit (QIAGEN, Hilden,
Germany) and on column digestion of genomic DNA was performed
using the RNase-free DNase set (QIAGEN). RNA concentrations were
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etermined with the Quant-itTM Ribogreen® RNA assay kit (Bio-
ad, Hercules, CA, USA). RNA quality assessment using microﬂuidic
apillary electrophoresis (Experion RNA HighSens Chip, Bio-Rad)
howed good quality RNA samples as determined by 18S/28S
RNA ratios (RNA quality index [RQI] 8.5 for positive control,
.3–9.4 for representative T lymphocyte samples; a RQI > 7 indi-
ates good quality). mRNA was transcribed to cDNA using the
ScriptTM advanced cDNA synthesis kit (Bio-Rad). cDNA concentra-
ions were subsequently estimated using the Quant-itTM oligreen®
sDNA kit (Life technologies). All kits were used according to the
anufacturer’s instructions. A commercially available Taqman®
ssay (Hs00984349 m1;  Life technologies) was used for ampliﬁca-
ion of serotonin transporter cDNA. 20 l reactions were prepared
ontaining 5 l of cDNA (500 ng input material), 10 l 2× ddPCRTM
uper mix  for probes (Bio-Rad), 1 l Taqman® assay and 4 l water.
dPCR assays were performed as described previously [20]. Brieﬂy,
roplets were generated in 8-channel cartridges containing the
0 l samples plus 50 l droplet generating oil using the QX100TM
roplet generator (Bio-Rad). Subsequently, droplet-in-oil suspen-
ions were transferred to 96 well plates and placed into a T100TM
hermal Cycler (Bio-Rad). Cycling conditions were as follows: 95 ◦C
or 5 min, followed by 40 cycles of 95 ◦C for 15 s and 60 ◦C for
0 s. Subsequently, the droplets were automatically read by the
X100TM droplet reader (Bio-Rad) and the data were analyzed with
he QuantaSoftTM analysis software 1.2.10.0 (Bio-Rad). All sam-
les were tested in duplicate. No-template controls (NTCs) were
ncluded in every ddPCR run. HEK 293 cells stably transfected with
SERT (kind gift from Randy Blakely, Vanderbilt University) were
sed as a positive control.
.8. Western blotting
107 cells were lysed in 1 ml  radioimmunoprecipitation (RIPA)
uffer containing 150 mM sodium chloride, 1.0% NP-40, 0.5%
odium deoxycholate, 0.1% SDS, 50 mM Tris, pH 8.0 and supple-
ented with 5 mg/ml  Complete Mini protease inhibitor cocktail
Roche, Basel, Switzerland), 10 l/ml phosphatase inhibitor cock-
ails 2 and 3 (Sigma-Aldrich) and 1 l/ml benzonase® nuclease
Sigma–Aldrich). 50 g of total protein was subjected to 10%
odium dodecyl sulphate polyacrylamide gelelectrophoresis (SDS-
AGE) and transferred to polyvinylidene diﬂuoride (PVDF)
embrane using Tris–glycine buffer (25 mM Tris base, 190 mM
lycine, 0.05% SDS), as described elsewhere [21]. Serotonin trans-
orter protein was detected with a 1:5000 dilution of ST51-1
aa51-66) mouse monoclonal anti-human serotonin transporter
ntibody (Santa Cruz Biotechnology, CA, USA) in PBS + 0.3%
ween-20 + 10% nonfat dry milk overnight at room temperature.
ncubation with secondary goat anti-mouse poly-HRP antibody
Thermo Fisher Scientiﬁc, Waltham, Massachusetts, USA) (1:1000
ilution) was performed during 1 h at room temperature in
BS + 0.3% Tween-20 + 5% nonfat dry milk. Protein bands were
etected with enhanced chemiluminescence. HEK 293 cells, stably
ransfected with hSERT were used as a positive control. Speciﬁcity
f the primary antibody was conﬁrmed with a blocking peptide
PSPGAGDDTRHSIPAT; Thermo Fisher Scientiﬁc, Waltham, Mas-
achusetts, USA). The ST51 antibody was incubated for 2 h at room
emperature with the blocking peptide at 5-fold excess in PBS, as
escribed elsewhere [21]. Then, the antibody-peptide mixture was
urther diluted in PBS containing 0.3% Tween-20 and 5% nonfat dry
ilk and added to the membrane..9. Detection of T cell activation
In order to detect T cell activation, T cells were stimulated with
nti-CD3/CD28 beads in a 1:1 bead:cell ratio for 5 h at 37 ◦C and 5% 58 (2015) 254–263
CO2. Fluoxetine or BAPTA-AM were added 30 min  before addition
of the T cell stimulus and were maintained in the culture medium
throughout the experiment. After 5 h incubation, cells were stained
with anti-human CD69 PECy7 and anti-human CD3 PECy5 (eBio-
science, San Diego, CA, USA) for 30 min  in PBS + 1% bovine serum
albumin and 0.1% NaN3, washed once and analyzed on a FC500
(Beckman coulter, Fullerton, CA, USA).
3. Results
3.1. Fluoxetine suppresses Ca2+ signaling in response to T cell
receptor activation
In order to analyze the effect of ﬂuoxetine on Ca2+ signaling
when T cells are activated through the T cell receptor (TCR), we acti-
vated Jurkat T cells with magnetic particles coated with antibodies
against CD3 and CD28 and analyzed the resulting changes in [Ca2+]i
through labeling with the ﬂuorescent Ca2+ dye ﬂuo3-AM. The
ﬂuorescent images obtained and the response of T cells to the anti-
CD3/CD28 beads are illustrated in Fig. 1A. After each experiment, T
cells making contact with at least one magnetic bead were visual-
ized and selected for analysis. The changes in ﬂuorescent signal over
time (arbitrary units, A.U.), which relate to changes in [Ca2+]i, were
plotted and result in a Ca2+ trace. The majority of cells in the control
samples (83%) responded to contact with a bead with a short period
of Ca2+ oscillations followed by a sustained increase in [Ca2+]i. A
small percentage of cells showed an oscillatory pattern (11%) or
transient response (6%) after contact with a bead (Fig. 1B). The same
types of responses were found in T cells pre-incubated with 10 M
ﬂuoxetine. A slight shift from sustained responses (75%) toward
oscillatory (13%) and transient (12%) responses was observed, but
no signiﬁcant changes were detected as compared to control (Chi-
square test, p = 0.28). However, ﬂuoxetine did affect the magnitude
of the response to TCR activation. T cells that were pre-incubated
for 30 min with 10 M ﬂuoxetine (F10) responded with oscilla-
tions with smaller amplitude and a weaker sustained increase in
[Ca2+]i. At 100 M ﬂuoxetine (F100), the response to TCR activa-
tion was  almost completely absent (Fig. 1C). Viability of the cells
was assessed by trypan blue staining at the end of the experiment
and no increased cell death was observed in samples pre-incubated
with ﬂuoxetine compared to control samples (data not shown).
The absence of a response in samples incubated with 100 M ﬂu-
oxetine was  thus not due to loss of viability. In order to quantify
the different responses, we calculated the difference between the
maximum of the Ca2+ peak (maximum value of 0–720 s) and the
baseline (mean of 0–120 s). Whereas the mean ± SD peak height
of control T cells was 59.18 ± 30.38 (A.U.), the mean peak height
of T cells pre-incubated with F10 was 50.97 ± 28.16 (p = 0.041)
(Fig. 1D). Cells pre-incubated with F100 showed a dramatically
reduced response to TCR activation, with a mean peak height of
only 7.45 ± 7.05 (p < 0.0001). Similar results were obtained when
the area under the [Ca2+]i trace was analyzed instead of the peak
[Ca2+]i change (data not shown). These results show that ﬂuoxe-
tine inhibits the Ca2+ signaling pathway following TCR activation
in a concentration-dependent manner in T lymphocytes.
3.2. Interference of ﬂuoxetine with intracellular stores or
capacitative Ca2+ entry
We  next questioned whether the observed suppression of
[Ca2+]i responses by ﬂuoxetine was due to either inhibition of
capacitative Ca2+ entry or interference with the release of Ca2+ from
intracellular stores. To this end we  added thapsigargin (TG), a selec-
tive inhibitor of sarco-endoplasmic reticulum Ca2+-ATPase (SERCA)
that prevents reuptake of Ca2+ into the ER, to the cells in Ca2+-free
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Fig. 1. Effect of ﬂuoxetine on Ca2+ signaling in response to TCR activation. T cells were stimulated with magnetic beads coated with anti-CD3 and anti-CD28 antibodies.
(A)  It shows a series of images taken after addition of anti-CD3/CD28 beads (beads were added at 120 s). The upper right image is a bright ﬁeld image taken at the end
of  the experiment, in which the location of the beads can be seen. The lower right image is a magniﬁcation of the marked area above. Scale bars are 50 m.  Color scale
shows  the pseudocolors in the RGB color mode assigned to the 256 shades of gray in an 8-bit image. (B) Representative Ca2+ responses induced by anti-CD3/CD28 beads
in  individual cells. Contact with a bead triggered sustained (top), transient (middle) or oscillatory (bottom) responses. The arrow indicates the addition of the beads. (C)
Representative traces of T cells activated with anti-CD3/CD28 beads in Krebs buffer (contr), 10 M ﬂuoxetine (F10), 100 M ﬂuoxetine (F100) or without beads (negative
control). For the negative control, the arrow indicates addition of an equal amount of buffer without beads. (D) Peak height of the Ca2+ response of T cells when stimulated
with  anti-CD3/CD28 beads in Krebs buffer (contr) or ﬂuoxetine (10 M, F10 and 100 M,  F100). Peak height was calculated as the difference between the maximum and
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**  = p < 0.0001.
uffer containing EGTA. Ca2+ exits the ER through a yet unidenti-
ed basal leak system, and blockage of SERCA consequently results
n depletion of the ER. After a 5 min  incubation period with TG that
llowed the ER to be completely emptied (conﬁrmed by subsequent
ddition of 50 M cyclopiazonic acid or 100 M thapsigargin, data
ot shown), Ca2+-containing buffer (1.5 mM Ca2+) was added, thus
llowing the cells to reﬁll their ER with Ca2+ through capacitative
a2+ entry (Fig. 2A). The impact of ﬂuoxetine on both steps was ana-
yzed. Interestingly, 30 min  pre-incubation of ﬂuoxetine reduced
he magnitude of the TG-induced Ca2+ release in a concentration-
ependent manner (control median 7.90, range [−75.54–192.90];
10 3.35, [−58.45–180.27], p < 0.0001; F100 1.12, [−22.14–99.43],
 < 0.0001; Fig. 2B). No signiﬁcant differences could be detected
ith respect to the magnitude of the peak after addition of Ca2+-
ontaining buffer (control median 38.00, range [7.0–217.3]; F10
4.55, [5.2–196.1]; F100 41.00, [3.3–208.7]; p = 0.423; Fig. 2C).
imilar results were obtained when using anti-CD3/CD28 beads
nstead of TG to stimulate the cells. Whereas the initial response
o the beads in Ca2+-free buffer was suppressed by ﬂuoxetinenalysis. In total, 89–146 bead-bound cells per condition were analyzed. * = p < 0.05.
(control median 2.69, range [−6.2–85.2]; F10 1.84, range
[−2.2–50.1], p = 0.47; F100 0.00, range [−6.7–46.1], p < 0.0001), the
capacitative Ca2+ entry was not signiﬁcantly affected by ﬂuoxe-
tine (control median 42.26, range [2.4–179.3]; F10 47.06, range
[12.0–135.5], p = 0.24; F100 31.50, range [2.3–120.8], p = 0.058)
(Fig. 2D–F). These data suggest that ﬂuoxetine might interfere with
Ca2+ release from intracellular stores. In contrast, ﬂuoxetine does
not appear to affect capacitative Ca2+ entry in T lymphocytes.
3.3. Effect of ﬂuoxetine on intracellular Ca2+ stores
The observed inhibition of Ca2+ release from intracellular stores
could be due to either depletion of the stores or direct inhibi-
tion of Ca2+ channels responsible for Ca2+ release from the ER.
To differentiate between both options, a series of experiments
was conducted studying the direct effect of ﬂuoxetine on [Ca2+]i.
Addition of ﬂuoxetine to resting T cells induces a rise in [Ca2+]i
both in Ca2+-containing and Ca2+-free buffer (Fig. 3A and B). These
data indicate that ﬂuoxetine partially depletes the intracellular
258 V. Gobin et al. / Cell Calcium 58 (2015) 254–263
Fig. 2. Effect of ﬂuoxetine on intracellular Ca2+ release and capacitative Ca2+ entry. Krebs buffer was replaced with Ca2+-free buffer immediately before imaging and 10 M
TG  (A–C) or 25 l anti-CD3/CD28 beads (D–F) were added at 120 s. At 420 s, Ca2+-free buffer was  replaced with Ca2+-containing buffer (1.5 mM Ca2+). Cells were pre-incubated
with  ﬂuoxetine (10 M,  F10 and 100 M,  F100) in Krebs buffer for 30 min, and ﬂuoxetine was maintained in all added solutions. All conditions were repeated at least three
times.  Data were pooled for analysis. (A) Mean traces of cells in Ca2+-free Krebs buffer (contr), 10 M ﬂuoxetine (F10) and 100 M ﬂuoxetine (F100). Arrows indicate addition
of  thapsigargin (TG, peak 1) and Ca2+-containing buffer (Ca2+, peak 2). (B) Peak height of the Ca2+ change induced by TG (peak 1). Peak height was  calculated as the difference
between the maximum and the baseline. (C) Peak height of Ca2+ change induced by re-introduction of Ca2+-containing buffer (peak 2). (D) Representative traces of cells in
Ca2+-free Krebs buffer (contr), 10 M ﬂuoxetine (F10) and 100 M ﬂuoxetine (F100). Arrows indicate addition of anti-CD3/CD28 beads (beads, peak 1) and Ca2+-containing
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iuffer  (Ca2+, peak 2). (E) Peak height of the Ca2+ change induced by anti-CD3/CD28
he  baseline. (F) Peak height of Ca2+ change induced by re-introduction of Ca2+-con
tores, leaving less Ca2+ available for release upon stimulation. If
uoxetine depletes ER stores, it could be expected that capaci-
ative Ca2+ entry, which is activated upon emptying of the ER,
ight also be affected by ﬂuoxetine. However, the peak height
f the capacitative Ca2+ response after exposure of T cells to ﬂu-
xetine was not signiﬁcantly different from the response elicited
n control samples (control median 43.2, range [9.4–83.7]; F100 (peak 1). Peak height was calculated as the difference between the maximum and
g buffer (peak 2). *** = p < 0.0001.
44.9, [23.8–161.1], p = 0.19, Fig. 3B), conﬁrming previous obser-
vations that ﬂuoxetine pre-incubation does not alter capacitative
Ca2+ entry. Finally, it was conﬁrmed that acute depletion of
the ER stores with ﬂuoxetine is followed by a lower Ca2+ peak
in response to TG (Fig. 3C). From these data and those above,
it can be concluded that ﬂuoxetine depletes intracellular Ca2+
stores.
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Fig. 3. Fluoxetine depletes intracellular calcium stores. (A) T cells were incubated in Ca2+-containing Krebs buffer and 100 M ﬂuoxetine (F100) was  added at 120 s. (B)
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as  replaced for Ca2+-containing Krebs buffer (1.5 mM Ca2+). (C) Krebs buffer was r
r  Ca2+-free buffer (contr) was added at 120 s. Thapsigargin was added at 420 s. The
.4. Interference of ﬂuoxetine with IP3-induced Ca2+ release
In order to study in more detail the functional effect of ﬂuox-
tine on the ER, T cells were loaded with NPE-caged IP3 through
lectroporation, and IP3 was released during imaging through ﬂash
hotolysis. The height of the resulting [Ca2+]i peak was  measured.
n accordance with the results of ﬂuoxetine partially depleting
ntracellular Ca2+ stores, ﬂuoxetine reduced the height of the Ca2+
eak after release of IP3, although statistical signiﬁcance was only
eached at 100 M ﬂuoxetine (mean control 11.43 ± 11.81; F10
.98 ± 12.94, p = 0.11, F100 2.13 ± 2.65, p < 0.0001) (Fig. 4). Thus,
uoxetine suppresses IP3-mediated Ca2+ release from the ER.
.5. Interference of ﬂuoxetine with ryanodine receptor-mediated
a2+ release
In addition to IP3R, ryanodine receptors (RyR) are equally known
o regulate Ca2+ release from intracellular stores. Ca2+ released
y IP3R may  in turn activate RyR resulting in Ca2+-induced Ca2+
elease [22]. The functional effect of ﬂuoxetine on RyR-mediated
a2+ release was analyzed by addition of caffeine, which is known to
ctivate RyR [23]. Preliminary experiments to select the most suit-
ble concentration of caffeine showed a concentration-dependent
ncrease in [Ca2+]i upon exposure to caffeine in a range from 10 to
0 mM (data not shown). As 50 mM caffeine induced the strongest
ffect, we selected this concentration to study the impact of ﬂuox-
tine hereon (Fig. 5A). Responses of similar magnitude but shorter
uration were obtained when the experiment was repeated in Ca2+-
ree buffer, indicating that caffeine indeed released intracellular
a2+ followed by capacitative Ca2+ entry (data not shown). In order
o conﬁrm that the rise in [Ca2+]i induced by caffeine was due to
yR stimulation, cells were pre-incubated with an antagonistic con-
entration of ryanodine (200 M).  As shown in Fig. 5, ryanodine
ompletely suppressed the rise in [Ca2+]i induced by caffeine. Flu-
xetine suppressed the rise in [Ca2+]i in a concentration-dependent ﬂuoxetine (F100) or buffer (contr) was added at 120 s. At 420 s, Ca2+-free buffer
d with Ca2+-free buffer immediately before imaging and 100 M ﬂuoxetine (F100)
s depict the mean response of at least 50 cells.
manner (Fig. 5A). In order to quantify the effect of ﬂuoxetine on
the RyR-mediated Ca2+ release, the difference between the max-
imal and minimal [Ca2+]i was  calculated. Control cells showed a
median peak height of 17.5, range [2.8–74.9], F10 12.3, [0.4–50.8],
p < 0.0001 and F100 4.1, [0.0–57.8], p < 0.0001 (Fig. 5B). Thus,
ﬂuoxetine inhibits RyR-induced Ca2+-release in a concentration-
dependent manner.
3.6. Involvement of 5HT and SERT in the ﬂuoxetine-induced
effects on Ca2+ signaling
As ﬂuoxetine is known to inhibit serotonin uptake through the
SERT, we  next questioned whether the observed effects on Ca2+
signaling could be initiated by SERT inhibition. Therefore, we  ﬁrst
analyzed whether Jurkat T lymphocytes express SERT. As shown
in Fig. 6, T lymphocytes express SERT both at the mRNA level and
the protein level. Whereas the positive control (hSERT transfected
HEK293 cells) showed a protein band at ∼80 and 60 kDa, only the
60 kDa band was found in T cells. As described previously, the
∼80 kDa band presumably represents a highly glycosylated form of
SERT, whereas the 60 kDa band is most likely the unmodiﬁed SERT
protein [21]. Further, it should be noted that the large difference
in expression levels between the positive control and the T cells
is due to overexpression of SERT in the hSERT transfected cell line
[21]. Speciﬁcity of the primary antibody was conﬁrmed by incu-
bation with a blocking peptide. The results of these experiments
indicate that T lymphocytes do express SERT.
To investigate if the effects of ﬂuoxetine on Ca2+ signaling are
mediated by SERT inhibition, we analyzed the inﬂuence of a large
excess (1 mM)  5HT on the ﬂuoxetine-induced suppression of RyR-
mediated Ca2+ release (100 M ﬂuoxetine). If inhibition of SERT by
ﬂuoxetine causes the observed decrease in Ca2+ signaling, it can be
expected that 5HT reverses this effect by competing with ﬂuoxetine
for binding to SERT. As shown in Fig. 6C, 5HT did not inhibit the sup-
pression of RyR-mediated Ca2+ release by 10 or 100 M ﬂuoxetine
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Fig. 4. Effect of ﬂuoxetine on IP3-mediated Ca2+ release. T cells were electroporated with NPE-caged IP3 and IP3 was released by ﬂash photolysis after 120 s of imaging.
Imaging  was  continued for 5 min. Fluoxetine (10 M,  F10 and 100 M,  F100) was  added 30 min  before the start of the experiment. The peak height of the Ca2+ change
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ffter  photolytic release of IP3 was calculated as the difference between the maxim
f  electroporated cells within the ﬂash zone in Krebs buffer (contr), 10 M ﬂuoxeti
hanges after photolytic release of IP3. *** = p < 0.0001.
control median 21.70, [0.0–70.7] vs 5HT 20.70, [3.1–71.1], p = 0.61;
10 18.60, [0.9–60.3] vs F10 + 5HT 20.20, [−0.1–100], p = 0.35; F100
.30, [−0.9–62.2] vs F100 + 5HT 5.25, [−0.6–93.6], p = 0.18). Thus,
t is not likely that ﬂuoxetine depletes Ca2+ from the ER through
lockage of 5HT uptake by SERT. Notably, addition of 5HT (1 mM)
id not induce Ca2+ changes on its own (data not shown).
.7. The effect of ﬂuoxetine on T cell activation is mimicked by
uffering of intracellular Ca2+
In order to investigate whether the observed effect of ﬂuoxetine
n intracellular Ca2+ stores is at the basis of its immunosuppressive
ffect, we analyzed the effect of ﬂuoxetine on CD69 expression, an
arly activation marker. Incubation of T cells with anti-CD3/CD28
eads during 5 h in the absence of ﬂuoxetine induced a strong
pregulation of CD69 expression (Fig. 7). Non stimulated (‘NS’)
ells showed a mean ﬂuorescence intensity (MFI) of 10.29 ± 0.97,
hereas stimulated cells (‘S’) had a MFI  of 107.0 ± 3.0. Fluoxetine
100 M)  decreased the MFI  to 9.77 ± 1.97 (p < 0.0001 compared
ig. 5. Effect of ﬂuoxetine on RyR-mediated Ca2+ release. T cells were stimulated with 50 m
ere  performed in calcium-containing Krebs solution. (A) Individual traces of cells in Kre
timulated with 50 mM caffeine at 120 s (arrow on the graph). Fluoxetine was  added 30
B)  Calculated peak heights of the recorded Ca2+ changes. Per sample, 100 arbitrary cells w
or  analysis. *** = p < 0.0001.nd the baseline. A total of 61–111 cells per group were analyzed. (A) Mean traces
0) and 100 M ﬂuoxetine (F100). (B) Calculated peak heights of the recorded Ca2+
to‘S’). The same suppressive effect was found when cells were incu-
bated with BAPTA-AM (50 M),  an intracellular Ca2+ chelator added
to silence cytoplasmic Ca2+ changes, demonstrating that interfer-
ence with intracellular Ca2+ signals after TCR stimulation indeed
impairs T cell activation (MFI 18.27 ± 0.21, p < 0.0001 compared
to‘S’). Thus, the inhibitory effect of ﬂuoxetine on CD69 expression
can be mimicked by buffering the intracellular Ca2+ of the cells with
BAPTA-AM. These data show that interference with Ca2+ signaling
in T lymphocytes results in impaired T cell activation, as estimated
from CD69 expression, and that the effect of ﬂuoxetine is compara-
ble in magnitude to the effect of buffering [Ca2+]i with BAPTA-AM.
4. Discussion
In this report, we investigated the impact of ﬂuoxetine on Ca2+signaling in Jurkat T lymphocytes. Previous research has demon-
strated that ﬂuoxetine and other SSRIs exert anti-inﬂammatory
and immunosuppressive effects on T lymphocytes [3,24]. Similar
suppressive effects have been described in Jurkat T lympho-
M caffeine in the presence of different concentrations of ﬂuoxetine. The experiments
bs buffer (contr), 10 M (F10), 100 M (F100) ﬂuoxetine or 200 M ryanodine and
 minutes before the start of the experiment and maintained in all added solutions.
ere analyzed. Each condition was performed in duplicate and results were pooled
V. Gobin et al. / Cell Calcium 58 (2015) 254–263 261
Fig. 6. Analysis of SERT expression in Jurkat T lymphocytes and involvement of 5HT in the ﬂuoxetine-induced effects. (A) SERT mRNA expression was detected with ddPCR.
Samples were analyzed in duplo and compared to a positive control (hSERT transfected HEK293 cells); (B) SERT protein expression in hSERT HEK cells (positive control) and
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nd  100 M)  inhibition of caffeine-induced Ca2+ release. Cells were incubated wit
nalyzed in triplicate and data were pooled for analysis. Peak height expresses the 
ytes [25]. Although several hypotheses on the mechanism behind
he observed effects were investigated (reviewed in [2]), the
xact mechanism by which ﬂuoxetine suppresses T cell activa-
ion and proliferation was not clariﬁed. SSRIs have been shown
o affect Ca2+ signaling in several cell types including neurons [8],
ig. 7. Effect of ﬂuoxetine and BAPTA-AM on CD69 expression in activated T cells.
 cells were activated with anti-CD3/CD28 beads. BAPTA-AM (50 M)  or ﬂuoxetine
100 M,  F100) were added 30 min  before addition of the beads and the cells were
ncubated for 5 h at 37 ◦C and 5% CO2. Cells were stained with anti-human CD3 PECy5
nd CD69 PECy7 and analyzed by ﬂow cytometry. NS = non-stimulated cells. S = cells
timulated with anti-CD3/CD28 beads. Mean ± SD of mean ﬂuorescent intensities
MFI) are shown. Each condition was analyzed in triplicate. *** = p < 0.0001. ns = not
igniﬁcant.ptide; (C) Results of competition experiments with 5HT (1 mM)  on ﬂuoxetine (10
xetine and/or 5HT 30 min  before the start of the experiment. All conditions were
e-induced change in Ca2+. ns = not signiﬁcant.
astrocytes [9], microglia [10], osteosarcoma cells [11], platelets [13]
and adrenal medulla PC12 cells [7,26]. Since elevation of intra-
cellular Ca2+ plays a major role in the pathway leading to T cell
activation in response to antigens [6], we  investigated if SSRIs, in
particular ﬂuoxetine, interfere with this signaling pathway in T
cells.
In the case of T lymphocytes, Ca2+ is stored in the ER and release
from the ER is mediated predominantly by binding of IP3 to IP3R,
and is further regulated by RyR [27]. The majority of research con-
ducted on the effect of antidepressants, including SSRIs, on Ca2+
signaling in other cell types suggests interference with intracel-
lular Ca2+ stores [7,9,11,13]. In accordance with these data, we
demonstrated that ﬂuoxetine interferes with the ER Ca2+ stores in
T lymphocytes. As opposed to tricyclic antidepressants, we  found
that ﬂuoxetine inhibits IP3-induced Ca2+ release [28]. More speciﬁ-
cally, we demonstrated that ﬂuoxetine suppresses the rise in [Ca2+]i
in response to TCR activation. Additionally, we showed that the
decreased Ca2+ signaling is due to the inhibition of Ca2+ release
from ER stores, rather than the blockage of capacitative Ca2+ entry.
There are two  possible explanations for the inhibition of the Ca2+
release from intracellular stores: either ﬂuoxetine causes a deple-
tion of stored Ca2+ thus leaving less Ca2+ available for release after
IP3R or RyR activation, or ﬂuoxetine directly interferes with the Ca2+
channels blocking the Ca2+ release in response to IP3R or RyR acti-
vation. In accordance to Serafeim et al., who  found that ﬂuoxetine
and other SSRIs induced a rise in [Ca2+]i in malignant B cells [12],
the addition of ﬂuoxetine to resting T cells resulted in an increase
of the cytoplasmic Ca2+ concentration. Subsequent addition of TG
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Fig. 8. Schematic representation of ﬂuoxetine-induced effects on Ca2+ signaling
in  T lymphocytes. In T cell activation, binding of an antigen to the TCR results in
activation of PLC, which converts PIP2 to IP3 and DAG. IP3 induces Ca2+ release
from  the ER through activation of IP3R. Ca2+ may  in turn activate RyR thereby
further stimulating Ca2+ release. RyR agonists such as caffeine also induce Ca2+
release by RyR. Secondary to the release of Ca2+ from the ER, inﬂux of Ca2+
through the plasma membrane is induced. The rise in cytoplasmic Ca2+ eventu-
ally leads to transcription of a pleotropic set of genes, including IL2, resulting in
T  cell activation and proliferation. Fluoxetine depletes intracellular Ca2+ stores,
thereby leaving less Ca2+ available for release upon IP3R or RyR activation. As Ca2+
release from intracellular stores is an indispensable step in the pathway leading
to  T cell activation, inhibition of Ca2+ signaling by ﬂuoxetine results in impaired
T  cell activation and proliferation. Intermediate steps in the signaling transduc-
tion  pathway were omitted for clarity. TCR = T cell receptor, PLC = phospholipase
C;  PIP2 = phosphatidylinositol 4,5-bisphosphate; IP3 = phosphatidylinositol 3,4,5-
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It should be noted that the concentrations of ﬂuoxetine used
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Finally, we selected ﬂuoxetine to study the effects on Ca2+
signaling in T lymphocytes. As other SSRIs also induce immuno-
suppressive effects in T lymphocytes [3], it would be interesting to
investigate whether these compounds also affect Ca2+ signaling in
T lymphocytes.
In conclusion, these data show that ﬂuoxetine suppresses intra-
cellular Ca2+ signaling in Jurkat T lymphocytes through depletion
of Ca2+ from intracellular stores, an effect likely to be at the basis
of the observed immunosuppression.
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